Accelerating Cell & Gene Therapy with
Integrated CRO + CDMO Excellence
OranssiBio is a high-end research, development, and manufacturing service provider specializing in cell and gene therapies (CGT). We are committed to supporting global biopharmaceutical companies and research institutions with a fully integrated CRO + CDMO platform that spans the entire development lifecycle—from early-stage discovery and clinical trial material production to commercial-scale manufacturing.
Driven by the principles of quality, agility, and international compliance, OranssiBio is committed to accelerating the development of transformative CGT therapies — making advanced medicines accessible to more patients, and creating long-term value for society.
-
End-to-End Technology Platforms
Integrated platforms spanning plasmids, viral vectors, exosomes, mRNA-LNPs, and cell therapies — from concept to launch. -
High-Standard R&D and Manufacturing
From early development to GMP production, we ensure speed, scalability, and strict quality compliance. -
Global Regulatory Support
CMC-driven documentation and submission strategies tailored for FDA, EMA, NMPA, and global standards. -
Experienced Team Supporting Every Stage of the CGT Lifecycle
Cross-functional experts guiding you from discovery through clinical trials to commercial manufacturing.
Our Team
-
01
20+ years of average industry experience per team member. Direct involvement in the development and registration of 70+ marketed products.
-
02
Specialized knowledge spanning viral vectors, cell therapy, plasmids, exosomes, and mRNA delivery.
-
03
A client-first mindset, delivering tailored solutions with precision, efficiency, and accountability.
Our Vision
-
To be a globally trusted CGT partner, accelerating the path from discovery to patient impact. -
We enable biopharma innovators with integrated, flexible platforms for development, manufacturing, and regulatory success. -
Rooted in quality, innovation, and trust, we help advanced therapies reach more patients—faster.
